Copyright
©The Author(s) 2023.
World J Gastroenterol. May 21, 2023; 29(19): 2950-2960
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2950
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2950
Table 4 Multivariate analysis of risk factors accompanied with eradication therapy of Helicobacter pylori
| Variable | aOR (95%CI) | P value |
| s1 | 0.507 (0.175–0.822) | 0.003 |
| s2 | 0.074 (-0.227 to 0.393) | 0.595 |
| m1 | -0.028 (-0.291 to 0.234) | 0.83 |
| AMX | 0.223 (0.026–0.537) | 0.032 |
| CLR | 0.204 (-0.005 to 0.412) | 0.036 |
- Citation: Asaad AM, El-Azab G, Abdelsameea E, Elbahr O, Kamal A, Abdel-Samiee M, Abdelfattah A, Abdallah H, Maher D, El-Refaie A, Ghanem SE, Ansari S, Awad SM. Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases. World J Gastroenterol 2023; 29(19): 2950-2960
- URL: https://www.wjgnet.com/1007-9327/full/v29/i19/2950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i19.2950